RECENT NEWS

Beckman Coulter Life Sciences has announced the appointment of Joe Fox as President of the company, effective immediately.

A new white paper report commissioned by Abbott seeks to provide a constructive contribution to ongoing policy and legislative developments for medical devices and diagnostics. Its release comes as the new UK Government looks to refocus healthcare more towards prevention and closer to home through the use of the latest innovative technologies, and with a focus on regulatory innovation.

Research led by scientists at Queen Mary University of London is heralding in a new era for genetic sequencing and testing.

BioAI, a biotechnology company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with Arbele, a biopharmaceutical company dedicated to developing novel immunotherapeutic platforms for gastrointestinal cancers.

A collaborative research team led by Professor Chulhong Kim and Professor Chan Kwon Jung of Seoul St. Mary’s Hospital, Catholic University of Korea, has developed an artificial intelligence (AI) system to analyse the label-free photoacoustic histological images of human liver cancer tissues.

AI-powered pathology solutions provider Mindpeak has announced it has raised $15.3 million in a Series A funding round. This new investment will enable the company to further expand the commercialisation of its recently expanded suite of technologies across several new territories.

‘Breath biopsy’ firm Owlstone Medical has announced it has entered into a Research Collaboration Agreement with the US FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL). The goal of the collaboration is to develop methods for the confident identification of individual chemicals in the complex mixture of breath.

The Royal College of Pathologists (RCPath) has published a new Patient Safety and Quality Strategy as part of its ongoing aim to improve patient safety.

Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), committing to a clear set of targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030.

Government-led negotiations on the world’s first agreement to protect people from future pandemics made significant progress during the latest round of discussions that ended recently at the World Health Organization (WHO).

Diagnostic firm Cepheid has announced a new partnership with the Fleming Initiative, a global collaboration established by Imperial College Healthcare NHS Trust and Imperial College London to combat antimicrobial resistance (AMR).

Two newly published Alzheimer’s studies reveal details of the disease’s biology, risk for progression, and the potential for a novel blood test.

StatLab Medical Products has launched a new self-manufactured premium slide and coverglass brand. The KT premium slides are designed for high-performance in busy pathology laboratories.

Roche has launched the cobas Respiratory flex test, the first to use Roche’s novel and proprietary TAGS (Temperature-Activated Generation of Signal) technology. It is able to detect up to 12 of the most common respiratory viruses with the flexibility for targeted testing.

The Medicines and Healthcare products Regulatory Agency (MHRA), is calling for applications for manufacturers and developers of Artificial Intelligence (AI) medical devices, to join the AI Airlock regulatory sandbox.

A research team led by NHS Blood and Transplant scientists based in Bristol, at NHSBT’s International Blood Group Reference Laboratory (IBGRL), and supported by colleagues at the University of Bristol, has discovered a new blood group, MAL, solving a 50-year-old mystery.

Beckman Coulter and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, have announced expansion of their long-term partnership to include a global distribution agreement forScopio’s Full-Field Bone Marrow Aspirate (FF-BMA) application.

A new survey from Abbott shows that leading infectious disease experts around the world believe significant gaps remain in building surveillance programmes to identify emerging pathogens, public health funding and having adequate testing infrastructure capabilities.

A Company Chemists’ Association (CCA) report urges the NHS to commission a community pharmacy diabetes screening service which would save the NHS £50m in recurring costs each year.

The Institute of Biomedical Science (IBMS) has collaborated with Hologic to produce a new report on digital cytology which it says promises enhanced efficiency, improved patient care, and solutions to workforce shortages, amid critical challenges in the UK's cervical screening programme.